Coupled with a review of these results by experts on a molecular tumor board, the opportunity exists to
identify novel therapies that would target specific abnormalities,» notes senior author of the work, Shridar Ganesan, MD, PhD, associate director for translational science at Rutgers Cancer Institute and associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School.
Not exact matches
«Researchers
identify novel mechanism in combination drug
therapy for acute myeloid leukemia, other cancers.»
He hopes that further studies may
identify novel approaches to immune - based cancer
therapy or reveal new drug targets for inflammatory diseases.
This is important because it makes it possible to model almost any autoimmune disease, evaluate new drug
therapies, and even
identify novel targets in the emerging area of cancer immunotherapies.
The study authors write that using the LSC17 score to single out high - risk patients predicted to have resistant disease «provides clinicians with a rapid and powerful tool to
identify AML patients who are less likely to be cured by standard
therapy and who could be enrolled in trials evaluating
novel upfront or post-remission strategies.»
One GSC subtype called the mesenchymal GSC is more malignant and the most
therapy - resistant, so Nakano and fellow researchers reasoned that
identifying the regulatory molecules active in mesenchymal GSCs might lead to
novel and effective therapeutics.
Investigators with The Cancer Genome Atlas (TCGA) Research Network have
identified novel genomic and molecular characteristics of cervical cancer that will aid in the subclassification of the disease and may help target
therapies that are most appropriate for each patient.
«At Exeter we are already developing specific psychological
therapies, running clinical trials of
novel drug approaches and using - cutting edge genetic techniques to
identify new targets for safe and effective
therapies and to allow us to use current treatments in a more focussed way.»
«There are currently no drug
therapies available that improve the very limited natural recovery from spinal cord injuries that patients experience,» said Lyn Jakeman, Ph.D., a program director at the NIH's National Institute of Neurological Disorders and Stroke, Bethesda, MD. «This is a great step towards
identifying a
novel agent for helping people recover.»
Discovery of a
novel, advanced technique to
identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral
therapy (ART).
«We've
identified what leads to this difference in vision loss, and that suggests
novel potential
therapies to treat this serious medical problem in children.
«We are currently
identifying the genes responsible for generating the DNA tether, which could be promising
novel targets for the next generation of cancer
therapies.»
Other areas of research include designing
novel therapies based on molecular pathways and
identifying predictive biomarkers in patients to design personalized, targeted
therapies.
Researchers have
identified a
novel mechanism by which cells die in Alzheimer's disease, which my aid future
therapies targeting cell loss in the brain.
We now currently have enough information about genetic factors that contribute to glaucoma that we really can begin to
identify biological processes and proteins that contribute to the disease, making it possible to develop
novel therapies that actually target those processes and proteins.
My studies of cancer genomes have led to characterization of multiple pediatric and adult tumor types, to development of methods that
identify and characterize changes in genomic heterogeneity, to defining acquired resistance mechanisms to targeted
therapies and to designing
novel, personalized vaccines for individual patients.
At present, there is an urgent clinical need to extend our understanding of PD pathology, to develop
novel disease - modifying
therapies for PD, and to
identify reliable PD biomarkers to allow for earlier interventions.
A major goal is to integrate genetic, clinical, and laboratory features to
identify patients who share disease biology and clinical outcome, such that
therapies, both existing and
novel, can be better targeted.
My research efforts are focused on
identifying novel combination
therapies for breast cancer and the mechanisms that lead to drug resistance.
Drug screening in a zebrafish model of SCN1A mutation has
identified lead compounds for development of
novel therapies.
By
identifying novel molecular targets and potential new drugs, this powerful technological structure will contribute significantly to groundbreaking research towards the development of new anti-cancer
therapies.
His research focuses on developing new
therapies and
identifying novel prognostic and predictive biomarkers for canine lymphomas.
We also postulate that Treg frequency and Treg: CD8 + ratios will act as prognostic indicators of survival and may help
identify novel targets for anti-cancer
therapy.
* Expertise in developing
novel combination
therapies,
identifying drug resistance mechanisms, signaling pathways, tumor microenvironment.
Informed by the literature on risk factors for IPV maintenance, drawing from the broader psychopathology and psychotherapy literatures, and guided by third wave behavior
therapy models, Dr. Lawrence and her students developed a new conceptual model
identifying novel processes that underlie the propensity for violent perpetrators to continue engaging in IPV, applied that model to a
novel intervention, and then tested the efficacy and effectiveness of that new intervention.